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EgyptAbstract Background: Polymorphisms of genes encoding enzymes involved in folate metabolism
have long been hypothesized to be maternal risk factors for Down syndrome, however, results are
conflicting and inconclusive.
Aim of the study: To analyze the effect of methionine synthase (MTR) A2756G, and reduced
folate carrier (RFC1) A80G gene polymorphisms on the maternal risk for DS.
Patients: This study was conducted in the Medical Genetics Center, Ain-Shams University hos-
pitals, on a total of 170 mothers of children, diagnosed with Down syndrome, who were attending
the center. Eighty-five control mothers were also enrolled in the study.
Methods: Genotype analyses were performed using PCR-RFLP to detect RFC1A80G and
MTRA2756G gene polymorphisms in all case and control mothers.
Results: Comparing RFC1A80G genotype frequency between both groups revealed, that the fre-
quency of the AA genotype in case mothers (94.11%) is highly significantly (p< 0.001) greater than
its frequency in control mothers (74.11%), with no significant difference between the two groups
regarding GG genotype. Comparing RFC1 A80G allele frequency between the two groups revealed
a high frequency of the A allele among case mothers (94.11%), which showed a highly statistically
significant difference (p< 0.001) from the control group (55.29%), meanwhile the G allele showed
a low frequency of 5.88% in DS mothers compared to 22.35% in the control mothers, with a highly
statistically significant difference (p< 0.001) between the two groups. Regarding MTRA2756G
polymorphism, it was found that the AA genotype predominated in the control group (65.88%)
with a highly statistically significant difference (p< 0.001) from case mothers group (5.88%).
Comparing MTR allele frequency between the two groups revealed predominance of the G allele
among mothers of DS children (76.47%).
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Down syndrome (DS), the most frequent cause of mental
retardation in live-born infants, is mostly caused by the pres-
ence of three copies of chromosome 21, due to failure of chro-
mosomal segregation during maternal meiosis (meiotic
nondisjunction) [1].
The incidence of DS in Egypt varies between 1:555 and
1:770 [2], with an estimated risk of 2285 DS births annually
[3]. The well-established risk factor, advanced maternal age,
was not found in many of the Down syndrome cases in Egypt,
while other possible risk factors still have to be elucidated [4].
Studies suggest that chromosomal instability and abnormal
segregation may be caused by genomic DNA hypomethylation
[5,6].
Folate is the general term for a water-soluble B vitamin (vita-
min B9) which is naturally found in foods such as green leafy
vegetables, liver, beans, egg yolks, cereals, some citric fruits,
kiwis, and strawberries [7]. 5-Methyltetrahydrofolate (5-
methylTHF) is the main form of circulating folate in the plasma
and can be transported into the cells by means of folate carriers
and receptors, the best characterized being the ubiquitously
expressed reduced folate carrier (RFC), coded by the SLC19A1
gene (commonly known as RFC1 gene) [8]. Intracellularly, 5-
methylTHF functions as a methyl donor for homocysteine
(hcy) remethylation, a reaction catalyzed by the methionine
synthase (MTR) enzyme that transfers a methyl group from
5-methylTHF to hcy, forming tetrahydrofolate (THF) and
methionine. Methionine is then converted to S-adenosyl
methionine (SAM) by methionine adenosyltransferase, and
most of the SAM generated is used in transmethylation reac-
tions whereby it is converted to S-adenosylhomocysteine
(SAH) by transferring the methyl group to diverse biological
acceptors, including proteins and DNA [9]. Therefore, a folate
restriction results in aberrant cell growth, impaired DNA
methylation, and increases the rate of point mutations, chromo-
some damage, and aneuploidy [7,10,11].
Almost 15 years ago, it was hypothesized that polymor-
phisms of genes encoding enzymes involved in folate metabo-
lism could lead to aberrant methylation of peri-centromeric
regions of chromosome 21, favoring its abnormal segregation
during maternal meiosis. Subsequently, more than 50 small
case–control studies investigated whether or not maternal
polymorphisms of folate pathway genes could be risk factors
for the birth of a child with DS, yielding conflicting and incon-
clusive results [12].
2. Aim of the study
The aim of this study is to analyze the effect of two genetic
polymorphisms, MTR A2756G, and RFC1 A80G on the
maternal risk for DS.3. Patients
This study was conducted in the Medical Genetics Center,
Ain-Shams University hospitals, on a total of one hundred
seventy mothers of children, diagnosed with Down syndrome,
who were attending the center. Eighty-five control mothers of
healthy children were also enrolled in the study.
The work was done after taking acceptance of all partici-
pants and taking an informed consent to share in the study
as well as acceptance of ethics committee of the University.
The works have been carried out in accordance with the code
of Ethics of the World Medical Association (Declaration of
Helsinki) for experiments involving humans.4. Methods
4.1. DNA extraction
DNA was extracted from whole blood using a QIAamp Blood
mini-prep Kit (QIAGEN, Germany) according to manufac-
turer’s instructions Genomic DNA (300 ng) was amplified in
a final volume of 50 ll, containing 10 mM TRIS pH 8.3,
50 mM KCl, 1.5 mM MgCl2, 200 mM each dNTP, 1 lM of
each primer and 2U Taq polymerase (all reagents from MBI
Fermentas, St. Leon-Rot, Germany).
4.2. RFC1A80G genotype detection
Genotype analyses were performed using PCR-RFLP. The pri-
mers for amplification were: forward: 50-AG TGT CAC CTT
CGT CCC-30 and reverse 50-TCC CGC GTG AAG TTC
TTG-30. PCR conditions were 44 cycles of 30 s at 94 C, 30 s
at 52 C, and 45 s at 72 C, preceded by an initial denaturation
of 2 min at 94 C, and followed by a final extension of 7 min at
72 C. Three hours digestion with CfoI (Sigma) resulted in
three fragments of 125, 68, and 37 bp, in the presence of the
80G allele, while the 80A allele produced two fragments of
162 and 68 bp.
4.3. MTR A2756G genotype detection
Genotyping for the MTR A2756G polymorphism was carried
out using specific primers (forward: 50-CCA GGG TGC CAG
GTA TAC AG-30, and reverse: 50-GCC TTT TAC ACT CCT
CAA AAC C-30) to amplify a 498-bp fragment spanning the
polymorphism, followed by digestion with enzyme HaeIII,
that digests the fragment in the presence of the mutated G
allele giving three fragments of 300, 130 and 68 bp, while in
the presence of the normal A allele, a whole uncut fragment
of 498 bp appears.
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Results were analyzed using the Statistical Package of Social
Sciences (SPSS) computer software program, version 21.0
(Chicago, IL, USA). Data were presented in the form of fre-
quencies and percentages. Differences among groups were
tested using Pearson’s chi-square test (v2). A p value less than
0.05 was considered statistically significant.
5. Results
In the present study, two gene polymorphisms, namely,
RFC1A80G and MTRA2756G were studied in 170 case moth-
ers along with 85 control mothers.
In the current study, comparing RFC1A80G genotype fre-
quency in DS and control mothers (Table 1) revealed, surpris-
ingly, that the frequency of the AA genotype in mothers of DS
children (94.11%) is highly significantly (p< 0.001) greater
than its frequency in control mothers (74.11%), meanwhile
there was no significant difference between the two groups
regarding GG genotype. Comparing RFC1 A80G allele
frequency between the two groups (Table 2) revealed a high
frequency of the A allele among case mothers (94.11%), which
showed a highly statistically significant difference from theTable 1 RFC1 A80G genotype frequency in DS and control mothe
SNP Gene ID Genotype DS mothers N (%) C
rs1051266 6573 AA 160 (94.11)a 6
AG 0 (0)b 1
GG 10 (5.88)c 7
* OR= odds ratio; CI = confidence interval.
a A statistically significant difference in the frequency of AA genotype
b A statistically significant difference in the frequency of AG genotype
c No significant difference between the frequency of GG genotype in D
Table 2 RFC1 A80G allele frequency in DS and control mothers.
SNP gene ID Allele DS mothers N (%) Con
rs1051266 6573 A 160 (94.11)a 47 (
G 10 (5.88)b 19 (
* OR= odds ratio; CI = confidence interval.
a A statistically significant difference in the frequency of A allele betwe
b A statistically significant difference in the frequency of G allele betwe
Table 3 MTR A2756G genotype frequency in DS and control mot
SNP (gene ID) Genotype DS mothers N (%)
rs1805087 (4548) AA 10 (5.88)a
AG 60 (35.29)b
GG 100 (58.82)c
* OR= odds ratio; CI = confidence interval.
a A statistically significant difference in the frequency of AA genotype
b A statistically significant difference in the frequency of AG genotype
c A statistically difference between the frequency of GG genotype in Dcontrol group (55.29%), meanwhile the G allele showed a
low frequency of 5.88% in DS mothers compared to 22.35%
in the control mothers, with a highly statistically significant
difference between them (p< 0.001).
On the other hand, the current results concerning
MTRA2756G polymorphism, revealed that the AA genotype
predominated in the control group (65.88%) with a statisti-
cally highly significant difference (p< 0.001) from the DS
mothers group (5.88%), meanwhile, the GG genotype predom-
inated in the DS mothers group (58.82%), with a statistically
high significant difference (p< 0.001) from the control group
(23.52%) (Table 3). Comparing MTR allele frequency between
the two groups revealed predominance of the G allele among
mothers of DS children (76.47%) with a statistically high sig-
nificant difference (p< 0.001) from the control mothers
(22.35%) (Table 4). There was no significant difference
between the frequency of MTRA2756A allele in DS
(23.53%) and control mothers (43.52%).
6. Discussion
DS is the most common chromosomal abnormality in live
births. Many studies have assessed the association between
maternal gene polymorphisms involved in folate metabolismrs.
ontrol mothers N (%) P-value OR (95% CI)*
3 (74.11)a 0.000a 5.587 (2.505–12.464)
5 (17.64)b 0.000b (2.815–4.176)
(8.23)c 0.478c 0.696 (0.255–1.899)
between DS mothers and control mothers (p< 0.001).
between DS mothers and control mothers (p< 0.001).
S and control mothers (p> 0.05).
trol mothers N (%) P value OR (95% CI)*
55.29)a 0.000a 12.936 (5.997–27.904)
22.35)b 0.000b 0.217 (0.096–0.492)
en DS mothers and control mothers (p< 0.001).
en DS mothers and control mothers (p< 0.001).
hers.
Control mothers N (%) P value OR (95% CI)*
56 (65.88) a 0.000 a 0.032 (0.015–.071)
9 (10.58) b 0.000 b 4.606 (2.156–9.841)
20 (23.52) c 0.000 c 4.643 (2.582–8.35)
between DS mothers and control mothers (p> 0.001).
between DS mothers and control mothers (p> 0.001).
S and control mothers (p> 0.001).
Table 4 MTR A2756 G allele frequency in DS and control mothers.
SNP (gene ID) Allele DS mothers N (%) Control mothers N (%) P value OR (95% CI)*
rs1805087 (4548) A 40 (23.53)a 37 (43.52)a 0.416a 0.803 (0.473–1.363)
G 130 (76.47)b 19 (22.35)b 0.000b 11.289 (6.065–21.013)
* OR= odds ratio; CI = confidence interval.
a No significant difference in the frequency of A allele between DS mothers and control mothers (p> 0.05).
b A statistically significant difference in the frequency of G allele between DS mothers and control mothers (p< 0.001).
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[13]. RFC1, which is located in the intestinal mucosal mem-
brane, is responsible for the amount of folate available in the
cells through transport of 5-methyltetrahydrofolate [14].
To our knowledge, studies concerning the frequency of
RFC1 A80G or MTRA2756G gene polymorphisms as mater-
nal risk factor for DS in Egypt, are still lacking. However,
our results are in contrast to Coppede` et al. [15], who showed
a role for the 80GG genotype, but not for the 80AA genotype,
combined with theMTHFR 1298AA genotype in the maternal
risk for DS in an Italian population.
Another study performed in Southern Italy suggested that
the 80G allele might increase DS risk in mothers aged more
than 34 years at conception [16]. In addition, Yang et al.
[14], has shown that RFC1 80G allele, is associated with
increased risk of having a child with DS. However, Chango
et al. and Neagos et al. [17,18], have found no significant asso-
ciation between RFC1 A80G gene polymorphism and
increased risk for a mother to have a DS child.
Also conflicting with our results are those results of Wang
et al. [19], who concluded that women with RFC-1 G80G
genotype have increased risk of delivering a child with Down
syndrome in China. Subsequent studies evaluating the possible
contribution of this polymorphism to the maternal risk of hav-
ing a DS child were conflicting, however, two meta-analyses,
by Yang et al. and Coppede` et al. [14,20] suggested that it
could represent an independent maternal DS risk factor.
Moreover, despite that its functional role is still controversial,
the RFC1 80G>A polymorphism has been associated with
reduced red cell folate concentrations among healthy women
[21], and with reduced serum folate concentrations in mothers
of down syndrome children (MDS) [22]. However, less than
1.000 MDS were available for those meta-analyses, and sub-
group stratification yielded inconclusive results likely because
of the small case–control cohorts in each ethnic group
[14,20]. However, RFC1 80G allele frequency was higher in
Caucasian and Brazilian MDS (ranging between 49.0% and
54.0%) than in Asian ones (36.0–36.5%) [23]. Therefore, fur-
ther studies with larger sample size are required to clarify the
contribution of this polymorphism to the maternal risk of a
DS birth.
Another gene polymorphism, the MTR 2756A>G poly-
morphism (rs1805087), leading to the Asp919Gly substitution,
was the third variant of the folate pathway to be associated
with the maternal risk of having a birth with DS [24].
The contribution of the MTR 2756G allele to the maternal
risk of birth of a child with DS was investigated mainly in
European and mixed Brazilian populations, with smaller
reported allele frequencies of about 18–21% [23], while the
study by Liao et al. [25], showed G allele frequencies of less
than 10% in Asians. The functional role of MTR 2756A>Gwith regard to its possible contribution to circulating hcy,
folate, or vitamin B12 levels, revealed conflicting results [26].
In this regard, Coppede` et al. [12], recently screened a large
cohort of MDS and matched control mothers observing that
the MTR 2756A>G, was not associated with increased serum
folate levels in GG carriers [20,27].
Our results are in agreement with Bisellie et al. [28], who
found that theMTR 2756GG genotype is a maternal risk factor
for DS. However, other case–control studies failed to confirm
this association where some recent meta- analyses confirmed
that theMTR 2756A>G polymorphism is not an independent
maternal risk factor for a DS offspring [12,14,20,29].7. Conclusion
The current results provide strong evidence that the
MTRA2756G, as well as the RFC1 80 A genotypes could be
considered as maternal risk factors for DS in Egyptian
mothers.
However, more studies, on larger samples, are needed to
confirm the current results.
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